Skip to main content
Equibles
PCVX logo

PCVX · Vaxcyte, Inc.

Track PCVX — free

Use PCVX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PCVX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$58.07 -0.79 (-1.34%) At close · Aug 14
Market Cap
$8.64B
Shares
148.81M

Vaxcyte, Inc. Earnings Call Transcripts

Every quarterly earnings call for Vaxcyte, Inc. (PCVX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q1
2026-05-06
Vaxcyte, Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-2.30
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Vaxcyte, Inc. Q4 FY2025 Earnings Call
Confident tone VAX-31 Adult Phase III (Opus) Program Infant Program (VAX-31 / VAX-24) Competitive Positioning vs. PCV20 and PCV21
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Vaxcyte, Inc. Q3 FY2025 Earnings Call
Diluted EPS
$-1.56
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Vaxcyte, Inc. Q2 FY2025 Earnings Call
Diluted EPS
$-1.22
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Vaxcyte, Inc. Q1 FY2025 Earnings Call
Diluted EPS
$-1.04
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Vaxcyte, Inc. Q4 FY2024 Earnings Call
Confident tone Infant pipeline and VAX-24/VAX-31 infant programs VAX-31 clinical progress and Phase 3 advancement ACIP recommendations and preferred status
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Vaxcyte, Inc. Q3 FY2024 Earnings Call
Diluted EPS
$-0.83
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
Vaxcyte, Inc. Q1 FY2024 Earnings Call
Diluted EPS
$-0.85
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Vaxcyte, Inc. Q4 FY2023 Earnings Call
Confident tone VAX-24 adult program VAX-31 adult program Regulatory and competitive landscape (V116, ACIP)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q4
2023-04-17
Vaxcyte, Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q4
2022-02-28
Vaxcyte, Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q4
2021-03-29
Vaxcyte, Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–12 of 12 earnings calls
Key facts CIK 1649094 CUSIP 92243G108 13F (30d) 321 filings 316 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)